EuroPCR 2023 | Intravascular Lithotripsy (IVL) Balloon in the Treatment of Underexpanded Stents

Calcified coronary plaque (CCP) is a challenge for interventional cardiology. Stent underexpansion (SU) commonly associated with CCP could predispose to stent thrombosis or restenosis. Currently, SU in severe CCP can be treated by rotational atherectomy, orbital atherectomy, balloon cutting/scoring, non-compliant high-pressure balloons, or intravascular lithotripsy (IVL).

The aim of this meta-analysis was to determine the success rate of IVL treatment of SU in CCP. 

The primary endpoint was success rate of the IVL strategy, defined as adequate expansion of underexpanded stents. 

The analysis included 13 studies pooling 354 patients. Mean patient age was 71 years old, and most subjects were male. Follow-up was 2.6 months. The strategy was successful in 88.7% of cases. The mean minimal stent area (MSA) was reported in 6 studies; the pre-IVL value was 3.4 mm2 and the post-IVL value was 6.9 mm2.

Read also: EuroPCR 2023 | TAVR in Patients with Bicuspid Aortic Valve Stenosis.

The average stenosis diameter was reported in 7 studies, with a pre-IVL value of 69.4% and post-IVL value of 14.6%. The intraprocedural complication rate was 1.6%. 

Conclusion

Plaque modification with SU due to CCP with the use of IVL has proven to be safe, with a high success rate and very low incidence of complications.

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Intravascular lithotripsy for the treatment of underexpanded stents: A meta-regression. 

Reference: Caminti et al. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...